Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Uromitexan 1g/10ml solution for injection ampoules
0801000T0BBABAB
|
Uromitexan | Mesna | Malignant Disease and Immunosuppression | No data available |
|
Uromitexan 400mg tablets
0801000T0BBADAC
|
Uromitexan | Mesna | Malignant Disease and Immunosuppression | No data available |
|
Uromitexan 400mg/4ml solution for injection ampoules
0801000T0BBAAAA
|
Uromitexan | Mesna | Malignant Disease and Immunosuppression | No data available |
|
Uromitexan 600mg tablets
0801000T0BBAEAD
|
Uromitexan | Mesna | Malignant Disease and Immunosuppression | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.